Table 1.
National‐level estimates of HIV incidence and undiagnosed HIV prevalence in 2014 and time to diagnosis for individuals infected between 2011 and 2014 for France, by sex, HIV exposure group and country of birth
| Number of new HIV infections (95% CI) | Median time (in years) from infection to diagnosis (IQR) | Number of undiagnosed HIV infections (95% CI) | Population sizea (18 to 64 year) (95% CI) | Incidence rate per 10,000 (95% CI) | Prevalence of undiagnosed HIV per 10,000 (95% CI) | |
|---|---|---|---|---|---|---|
| MSM (all) | 2938 (2651 to 3290) | 2.7 (0.5 to 5.0) | 9181 (8065 to 10,125) | 311,480 (248,800 to 382,887) | 115.1 (89.6 to 141.9) | 298.5 (233.9 to 379.7) |
| MSM born in France | 2302 (2041 to 2628) | 2.6 (0.5 to 5.0) | 7157 (6111 to 8044) | 268,770 (214,684 to 330,385) | 104.5 (80.3 to 128.4) | 269.6 (210.0 to 343.2) |
| Born‐abroad MSMb | 636 (491 to 817) | 3.2 (1.2 to 5.5) | 2025 (1624 to 2459) | 42,710 (34,115 to 52,501) | 181.8 (130.7 to 243.4) | 480.2 (352.8 to 662.7) |
| Born‐abroad heterosexual women (all) | 1399 (1200 to 1626) | 3.1 (1.3 to 5.1) | 5159 (4398 to 5786) | 2,861,832 (2,859,872 to 2,863,092) | 5.0 (4.3 to 5.6) | 18.0 (15.4 to 20.2) |
| Heterosexual women born in SSA | 1029 (844 to 1209) | 2.9 (1.2 to 4.9) | 3811 (3270 to 4354) | 416,700 (416,414 to 416,883) | 25.1 (20.6 to 28.8) | 91.5 (78.5 to 104.4) |
| Born‐abroad heterosexual men (all) | 1221 (933 to 1604) | 4.5 (2.4 to 6.8) | 5265 (4409 to 6446) | 2,607,948 (2,597,354 to 2,617,203) | 4.7 (3.6 to 5.9) | 20.2 (16.9 to 24.7) |
| Heterosexual men born in SSA | 871 (657 to 1113) | 4.2 (2.1 to 6.4) | 3565 (2943 to 4316) | 459,234 (457,369 to 460,864) | 19.2 (14.5 to 23.7) | 77.6 (63.9 to 94.0) |
| Heterosexual women born in France | 403 (291 to 523) | 3.0 (1.0 to 5.4) | 1526 (1254 to 1828) | 17,111,885 (17,100,164 to 17,119,422) | 0.2 (0.2 to 0.3) | 0.9 (0.7 to 1.1) |
| Heterosexual men born in France | 561 (323 to 825) | 4.6 (1.9 to 7.0) | 2711 (2108 to 3476) | 16,411,594 (16,344,929 to 16,469,836) | 0.3 (0.2 to 0.5) | 1.6 (1.3 to 2.1) |
| PWID (all) | 86 (27 to 211) | 4.0 (1.8 to 6.5) | 357 (217 to 657) | 104,317 (80,727 to 132,800) | 10.2 (3.0 to 21.9) | 34.8 (19.5 to 63.2) |
| PWID born in France | 59 (10 to 169) | 4.3 (2.1 to 6.7) | 205 (91 to 512) | 89,860 (69,541 to 114,382) | 8.0 (1.2 to 18.2) | 23.1 (9.5 to 56.4) |
| PWID born abroadb | 28 (5 to 69) | 3.5 (1.5 to 6.0) | 153 (79 to 270) | 14,458 (11,185 to 18,418) | 23.6 (4.5 to 51.4) | 107.7 (55.0 to 202.6) |
| Total men | 4776 (4273 to 5335) | 3.4 (1.1 to 5.8) | 17,394 (15,723 to 19,147) | 19,410,383 | 2.5 (2.2 to 2.7) | 9.0 (8.1 to 9.9) |
| Total women | 1831 (1606 to 2123) | 3.1 (1.2 to 5.0) | 6803 (6026 to 7546) | 19,998,673 | 0.9 (0.8 to 1.0) | 3.4 (3.0 to 3.8) |
| Total | 6607 (6057 to 7196) | 3.3 (1.2 to 5.7) | 24,197 (22,296 to 25,944) | 39,409,056 | 1.7 (1.5 to 1.8) | 6.1 (5.7 to 6.6) |
CI, confidence interval; IQR, interquartile range; MSM, men who have sex with men; PWID, persons who inject drugs; SSA, Sub‐Saharan Africa.
Details are given in Appendix S5 in SM on how population sizes were obtained.
For born‐abroad MSM and PWID, we did not produce estimates of incidence, time to diagnosis and undiagnosed prevalence according to the country of birth; however, it is interesting to note that among newly diagnosed HIV cases, over 2009 to 2014, 28% of born‐abroad MSM were born in Haiti or in the Americas, 26% in Europe, 26% in North Africa or Asia or Oceania, and 19% in SSA, and 72% of born‐abroad PWID were born in Europe.